| Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes ME Dudley, JR Wunderlich, PF Robbins, JC Yang, P Hwu, ... Science 298 (5594), 850-854, 2002 | 3819 | 2002 |
| Gene-expression profiles in hereditary breast cancer I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ... New England Journal of Medicine 344 (8), 539-548, 2001 | 2175 | 2001 |
| Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 PF Robbins, RA Morgan, SA Feldman, JC Yang, RM Sherry, ME Dudley, ... Journal of Clinical Oncology 29 (7), 917-924, 2011 | 2002 | 2011 |
| Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric … JN Kochenderfer, ME Dudley, SH Kassim, RPT Somerville, RO Carpenter, ... Journal of clinical oncology 33 (6), 540-549, 2015 | 1990 | 2015 |
| Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 JN Kochenderfer, WH Wilson, JE Janik, ME Dudley, M Stetler-Stevenson, ... Blood, The Journal of the American Society of Hematology 116 (20), 4099-4102, 2010 | 1692 | 2010 |
| Activated STING in a vascular and pulmonary syndrome Y Liu, AA Jesus, B Marrero, D Yang, SE Ramsey, ... New England Journal of Medicine 371 (6), 507-518, 2014 | 1357 | 2014 |
| ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile A Wiestner, A Rosenwald, TS Barry, G Wright, RE Davis, SE Henrickson, ... Blood 101 (12), 4944-4951, 2003 | 1116 | 2003 |
| The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia Y Herishanu, P Pérez-Galán, D Liu, A Biancotto, S Pittaluga, B Vire, ... Blood, The Journal of the American Society of Hematology 117 (2), 563-574, 2011 | 1096 | 2011 |
| Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma AY Khakoo, S Pati, SA Anderson, W Reid, MF Elshal, II Rovira, ... Journal of Experimental Medicine 203 (5), 1235-1247, 2006 | 1006 | 2006 |
| A pilot trial using lymphocytes genetically engineered with an NY-ESO-1–reactive T-cell receptor: long-term follow-up and correlates with response PF Robbins, SH Kassim, TLN Tran, JS Crystal, RA Morgan, SA Feldman, ... Clinical Cancer Research 21 (5), 1019-1027, 2015 | 937 | 2015 |
| B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma RO Carpenter, MO Evbuomwan, S Pittaluga, JJ Rose, M Raffeld, S Yang, ... Clinical cancer research 19 (8), 2048-2060, 2013 | 765 | 2013 |
| Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome AP Hsu, EP Sampaio, J Khan, KR Calvo, JE Lemieux, SY Patel, ... Blood, The Journal of the American Society of Hematology 118 (10), 2653-2655, 2011 | 707 | 2011 |
| Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma B Ensoli, R Gendelman, P Markham, V Fiorelli, S Colombini, M Raffeld, ... Nature 371 (6499), 674-680, 1994 | 678 | 1994 |
| Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. RE Donahue, SW Kessler, D Bodine, K McDonagh, C Dunbar, ... The Journal of experimental medicine 176 (4), 1125-1135, 1992 | 664 | 1992 |
| EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression SD Dojcinov, G Venkataraman, M Raffeld, S Pittaluga, ES Jaffe The American journal of surgical pathology 34 (3), 405-417, 2010 | 606 | 2010 |
| p53 mutation is associated with progression in follicular lymphomas CA Sander, T Yano, HM Clark, C Harris, DL Longo, ES Jaffe, M Raffeld | 502 | 1993 |
| Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome RD Kim, DE Greenberg, ME Ehrmantraut, SV Guide, L Ding, Y Shea, ... American journal of respiratory and critical care medicine 178 (10), 1066-1074, 2008 | 461 | 2008 |
| Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis F Fend, MR Emmert-Buck, R Chuaqui, K Cole, J Lee, LA Liotta, M Raffeld The American journal of pathology 154 (1), 61-66, 1999 | 451 | 1999 |
| Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy WH Wilson, ML Grossbard, S Pittaluga, D Cole, D Pearson, N Drbohlav, ... Blood, The Journal of the American Society of Hematology 99 (8), 2685-2693, 2002 | 434 | 2002 |
| Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology RF Little, S Pittaluga, N Grant, SM Steinberg, MF Kavlick, H Mitsuya, ... Blood 101 (12), 4653-4659, 2003 | 423 | 2003 |
